Snowball logo
logo
CNTX_logo

Context Therapeutics Inc

CNTX NASDAQ
$2.92+$0.06  (2.1%)

Frequently asked questions

What sector does Context Therapeutics Inc (CNTX) operate in?

Context Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Context Therapeutics Inc (CNTX) current stock price?

As of the latest data, Context Therapeutics Inc stock price is $2.92, with a previous close of $2.86. Context Therapeutics Inc gained $0.06 in the last trading session, representing a 2.1% increase.

What is Context Therapeutics Inc (CNTX) current market capitalization?

Context Therapeutics Inc market cap is approximately 268.29 million.

What is Context Therapeutics Inc (CNTX) Earnings Per Share (EPS)?

The trailing EPS is -$0.24, and the forward EPS is -$0.43.

What is Context Therapeutics Inc (CNTX) EBITDA?

Context Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -9.69 million.

Does Context Therapeutics Inc (CNTX) pay dividends?

No. Context Therapeutics Inc does not pay a dividend.

When is Context Therapeutics Inc (CNTX) next earnings report?

Context Therapeutics Inc is expected to release its next earnings report on December 31, 2025.

What is Context Therapeutics Inc (CNTX) beta (volatility) score?

Context Therapeutics Inc has a beta of 1.970, suggesting it is more volatile than the market.